Moderna, Inc. (NASDAQ:MRNA) has been notified of an unsolicited 'mini-tender' offer by TRC Capital Investment Corporation to purchase up to 1,000,000 shares of Moderna's common stock at $107.56 per share, which is 4.44% lower than the closing price on September 1, 2023. Moderna does not endorse this offer and recommends shareholders not to tender their shares as the offer is below the current market value and is subject to numerous conditions. TRC Capital's offer avoids many disclosure and procedural requirements of the SEC that apply to offers for more than five percent of a company's outstanding shares.